|
|
Anti-Obesity Medications Demystified
Recorded for 2024 National Conference
|
|
Facebook
LinkedIn
E-Mail
|
(1078)
Category: 2024 National Conference, Billing and Coding, Cardiometabolic, Cert Exam Domain - Diagnosis, Cert Exam Domain - Planning, Diabetes, Diabetes Mellitus, Family, Lipids, Outpatient, Pharmacology, Recent Additions (show less)
|
Activity Duration| Content Expires: | July 15, 2025 (11:55 p.m. CT)
CE for this activity will not be available after this date. |
This CE activity was recorded for the 2024 AANP National Conference.  | This activity includes closed captioning. |
| Delivery Note: The content for this activity was previously presented during the 2024 AANP National Conference. If you already completed the content of this activity while attending the live or virtual conference, you should not complete this content a second time. Learners should only complete ONE delivery-method to earn credit. Completing multiple delivery options for the same activity is considered duplicate credit for the same content and will not be accepted by regulatory bodies. |
Overview
Obesity is a chronic, progressive, relapsing disease that is treatable. Pharmacotherapy is one of the four pillars of comprehensive obesity treatment and may increase adherence to the other three pillars of nutritional therapy, physical activity, and behavior modification. Despite their safety and efficacy, only 1.3% of those eligible receive a prescription for FDA-approved anti-obesity medications. This presentation will help you unlearn any outdated or biased beliefs about these medications and learn the latest science on how you can use them safely and effectively. Real-life clinical scenarios will help you learn how to select, initiate, titrate, and monitor these medications. Tips and strategies for personalized medication selection based on complications, co-existing conditions, symptoms, patient preference, cost, and insurance coverage will be provided.
Objectives
- Explain the role of pharmacotherapy in comprehensive obesity treatment.
- Describe the criteria for patient eligibility for anti-obesity medications.
- Identify the available FDA-approved anti-obesity medications, including mechanism of action, contraindications, interactions, and adverse effects.
- Describe how to initiate, titrate, and monitor response to medications, including criteria for continuation and discontinuation.
Speaker
Sandra Christensen, MSN, ARNP, FNP-BC, MFOMA, FAANP
Disclosure
This program was planned in accordance with AANP CE Standards and Policies.
The speaker has the following disclosures:- I am a speaker for Novo Nordisk for obesity.
- I am a speaker and am on the advisory board for Eli Lilly for obesity.
- I am on an advisory board for Abbott for nutrition/obesity.
All relevant financial relationships have been mitigated.
DisclaimerIndividuals who have contributed to the CE Center (content originally from the 2024 AANP National Conference) were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
CE Credit Instructions
- Read this activity description, including objectives and disclosures.
- Complete all educational content:
- OnDemand Presentations: Click the Play button to watch the activity video lecture. To get full credit for the learning activity portion, you must watch all of the video content.
- Click on the Additional Resources button to review all additional materials provided (handouts and any other downloadable resources).
- After completing all educational content, go to the Next Steps button:
- Submit the activity evaluation to receive full AANP CE/Rx credit.
- Click on the Get Certificate button. At the top of the certificate screen, use the provided dropdown menu and select AANP Certificate of Completion.
- A copy of your certificate of completion will display on the screen for you to print or save. A copy of the certificate will also be emailed to you.
- A copy of the certificate will be automatically added to your AANP CE Tracker.
Additional Information
For questions or more information concerning this online CE activity, please visit the AANP Help Center to find answers to frequently asked questions and request assistance.
1.15 Contact Hour(s) of CE,
All of which may be applied towards Pharmacology
|
|
Additional CE activities of interest
(OnDemand)
Pharyngitis, Sinusitis, Otitis Media, Otitis Externa across the lifespan
(OnDemand)
Antibiotics And Infection in Acute Care: Update 2024
(OnDemand)
Balancing Act: Strategies for Tackling Dizziness
(OnDemand)
A Focus on Men’s Health: Erectile Dysfunction And Testosterone Deficiency
(OnDemand)
Back Pain? Don't Misdiagnose This!
(OnDemand)
Evaluation and Management of Classical and Atypical GERD
(OnDemand)
Infectious Disease Update 2024
(OnDemand)
I Think I Tore My Rotary Cup: Shoulder Evaluation for the Primary Care and Acute Care Provider
(OnDemand)
Using Clinical Guidelines To Optimize Obesity And Diabetes Care
(OnDemand)
A High-Level View of Medication Prescribing Challenges
(OnDemand)
Genitourinary Syndrome Of Menopause: How Do We Help Our Patients?
(OnDemand)
2024 ACIP Immunization Update: Latest best practices
|
|
Adding Registration, Please wait...
